Risk factors for microbiologic failure in children with Enterobacter species bacteremia.

Juri BoguniewiczPaula A RevellMichael E ScheurerKristina G HultenDebra L Palazzi

Published in: PloS one (2021)

Source of infection and adequacy of source control are important considerations in preventing microbiologic failure. In-vitro susceptibilities can be used to select an antibiotic regimen for the treatment of Enterobacter BSI in children.

Keyphrases

young adults
replacement therapy